Table 1 Clinical characteristics of study participants

Age (years)

< 0.001

 N

105

37

22

46

 Mean ± SD

46.7 ± 13.8

53.4 ± 12.8

37.4 ± 11.7

41.2 ± 12.1

 Min–Max

18.0–74.0

20.0–74.0

20.0–70.0

18.0–68.0

 Median(Q1-Q3)

46.0(32.0–54.0)

53.0(47.0–66.0)

36.0(28.0–44.5)

38.5(31.3–51.0)

BMI (kg/m²)

0.618

 N

105

37

22

46

 Mean ± SD

22.5 ± 2.9

22.2 ± 2.7

22.5 ± 2.4

22.8 ± 3.2

 Min–Max

16.0–30.0

17.5–27.9

18.4–28.2

16.0–30.0

 Median(Q1-Q3)

22.4(20.3–24.1)

21.8(20.2–24.1)

22.6(21.2–23.4)

22.4(20.3–25.5)

OV

 Serous (%)

33(89.2)

33(89.2)

N/A

N/A

 Mucinous (%)

2(5.4)

2(5.4)

N/A

N/A

 Endometrioid (%)

1(2.7)

1(2.7)

N/A

N/A

 Others (%)

1(2.7)

1(2.7)

N/A

N/A

FIGO stage

N/A

N/A

 IA(%)

1(2.7)

1(2.7)

N/A

N/A

 IC(%)

8(21.6)

8(21.6)

N/A

N/A

 IIB(%)

1(2.7)

1(2.7)

N/A

N/A

 III(%)

2(5.4)

2(5.4)

N/A

N/A

 IIIA(%)

2(5.4)

2(5.4)

N/A

N/A

 IIIC(%)

20(54)

20(54)

N/A

N/A

 IV(%)

2(5.4)

2(5.4)

N/A

N/A

 IVB(%)

1(2.7)

1(2.7)

N/A

N/A